Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Instructions for injections is easy
Research Context This compound is the subject of ongoing scientific investigation
The December 2024 FDA advisory committee cited insufficient safety data for the injectable route as one reason for declining to approve compounding
Laboratory Tests: During the initial treatment of patients with pernicious anemia, serum potassium must be observed closely the first 48 hours and potassium replaced if necessary
Pregnant or breastfeeding women should not use AOD-9604 due to lack of safety data in these populations
US$ 27.36
US$ 20.00
US$ 23.06
US$ 26.63
US$ 27.38
US$ 28.91
US$ 24.21
US$ 23.22
US$ 28.00
